
Oncology Spotlight: Exploring CRT, Immunotherapy and AI in cancer care with Prof. Gerry Hanna
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Acerca de esta escucha
Welcome to the Oncology Spotlight! In this episode, join us as we delve into the forefront of cancer care with Professor Gerry Hanna, a distinguished radiation oncologist and Marie Curie Chair of Clinical Oncology at Trinity College Dublin.
Key Discussion Points:
Introduction: Get to know Professor Gerry Hanna and his illustrious career spanning leading institutions like Queen’s University Belfast and the University of Melbourne.
Latest Developments in Lung Cancer Treatment: Professor Hanna shares groundbreaking advancements shaping the future of lung cancer care.
Evolution of CRT in Lung Cancer: Discover insights into how Combined Radiation Therapy (CRT) has progressed over the past five years.
Interpreting Scans Post-CRT: Learn about challenges and strategies in interpreting scans, especially in conjunction with immunotherapy.
Emerging Guidelines for Scan Interpretation: Professor Hanna outlines emerging best practices crucial for accurate treatment decisions.
Role of Multidisciplinary Teams (MDT): Understand the pivotal role MDTs play in enhancing diagnostic accuracy and treatment planning.
Current Research Initiatives: Explore ongoing research projects like PERTAIN and CONCORDE and their potential impact on cancer care.
Challenges in Oncology Today: Professor Hanna discusses the significant challenges facing oncology and strategies to overcome them.
Future Prospects with AI: Gain insights into the promising intersection of oncology and artificial intelligence (AI).
Don't miss this enlightening conversation that promises to deepen your understanding of cutting-edge oncology practices and future directions in cancer treatment.
🎧 Listen to the full podcast episode: LINK and join the conversation!